Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(13%)
Results Posted
67%(4 trials)
Terminated
1(13%)

Phase Distribution

Ph phase_4
2
25%
Ph not_applicable
3
38%
Ph phase_2
1
13%
Ph phase_3
1
13%

Phase Distribution

0

Early Stage

1

Mid Stage

3

Late Stage

Phase Distribution7 total trials
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
1(14.3%)
Phase 4Post-market surveillance
2(28.6%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

85.7%

6 of 7 finished

Non-Completion Rate

14.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

8

all time

Status Distribution
Active(1)
Completed(6)
Terminated(1)

Detailed Status

Completed6
Recruiting1
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
1
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 21 (14.3%)
Phase 31 (14.3%)
Phase 42 (28.6%)
N/A3 (42.9%)

Trials by Status

recruiting113%
completed675%
terminated113%

Recent Activity

Clinical Trials (8)

Drug Details

Intervention Type
DRUG
Total Trials
8